Immunogenicity University debuts at IIR's Bioassays and Bioanalytical Method Development event

For the first time on the West Coast, the Immunogenicity University full-day summit at Bioassays and Bioanalytical Method Development 2012 will give you the training you need for the design, validation, and smooth transfer of robust immunoassays.

Experts at all career stages will benefit from these in-depth sessions that emphasize troubleshooting, improving result quality and turnover time, and matching the expectations of regulatory reviewers.

Walk away with in-depth knowledge from the leaders in research & development:

• - Fundamentals of Immunogenicity Assessment 
• - Presented by Edwin Golez, Scientist, AMYLIN PHARMACEUTICALS & Valerie Theobald, PhD, Scientific Associate Director, Clinical Assay Development, GENZYME
• - Trusting your Data Chain: Assay Transferability 
• -Presented by Shobha Purushothama, PhD, Principal Scientist, PKDM, BIOGEN IDEC and Shelley Belouski, PhD, Principal Scientist, Clinical Immunology Outsourcing, AMGEN
• - Plan for Challenges in Preclinical and Clinical Development of Anti-Therapeutic Antibody Assays 
• - Presented by Sally Fischer, PhD, Group Leader, Bioanalytical R&D, GENENTECH & Kate Peng, PhD, Scientist, GENENTECH
• - Intensive Skill-Builder for Statistical Analysis 
• - Presented by Martin Kane, PhD, Director of Process Statistics, HUMAN GENOME SCIENCES and Lanju Zhang, PhD, Senior Principal Statistician, MEDIMMUNE

For more information on the Immunogenicity University and the rest of the program, download the agenda.

The 8th annual Bioassays and Bioanalytical Method Development conference will take place October 1-3, 2012 in Berkley, California. As a reader of this blog, when you register to join us today and mention code XP1768LINK, you’ll save 15% off the standard rate! If you have any questions, feel free to contact Jennifer Pereira.

Share this article with your social network, just click below to share now!

Share |